Board appointments at Oxygen Biotherapeutics
This article was originally published in Scrip
Executive Summary
Oxygen Biotherapeutics (US) has expanded its board of directors with the appointments of Rene Eckert and the Honourable William Chatfield. Mr Chatfield most recently served as director of the US Selective Service System, having been nominated by President George W Bush and confirmed by the US Senate. Mr Eckert was chairman, CEO and partner at Boehme Filatex from 1981-2007.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.